BILLS-116hr5668rh.pdf

01:13 Nov 17 30 days NOVEMBER 16, 2020 2020 January 24, 2020 every 4 years later than 4 years

SESSION H. R. 5668 the ‘‘Making Objective Drug

PO 00000 PO 00000 Frm 00005 PO 00000 Frm 00006 PO 00000 Frm 00007 PO 00000 Frm 00009 PO 00000 Frm 00001 PO 00000 Frm 00004 PO 00000 Frm 00008 Fmt PO 00000 Frm 00003 PO 00000 Frm 00002 PO 00000 Frm 00010 PO 00000 Frm 00011 Fmt

the United States of America

GE- Cosmetic

the Federal Food, Drug CONGRESS the State of the Union Committee on Energy and Commerce House the Committee of the Whole House THE HOUSE OF REPRESENTATIVES the Whole House the Committee on Health, Education Senate NERIC HOLDER House of Representa- SEC the Committee on Energy and Commerce IB Union Calendar No SPONSE Pensions of the Senate the Making Objective Drug Evidence

GUTHRIE MATSUI TAYLOR

labeling covered drug clinical practice drugs covered drugs drug generic reflected scientific evidence modernize cosmetic act drug cosmetic cosmetic federal food